Supernus Announces First Quarter 2025 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
- Nebius shares sink on CoreWeave's bond yield spike and insider sales
- IonQ prices $2 billion equity offering at $40 per share
- Rocket Lab delays Neutron rocket debut to 2027
- Bloom Energy stock falls as inflation data pressures markets
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
Supernus Pharma (SUPN) Misses Q1 EPS by 58c, Beats on Revenue
May 6, 2025 4:35 PM EDTSupernus Pharma (NASDAQ: SUPN) reported Q1 EPS of ($0.21), $0.58 worse than the analyst estimate of $0.37. Revenue for the quarter came in at $149.8 million versus the consensus estimate of $146.9 million.
For earnings history and earnings-related data on Supernus Pharma (SUPN) click here.
... More


